Malignant Tumours after Renal Transplantation

REFERENCES

• Blohme I, Brynger H. Malignant disease in renal transplant patients. Transplantation 1985; 39: 23–25.
   PubMed Web of Science ®Google Scholar
• Bordes-Aznar J, Mancilla E, Rosenblum M, et al. Malignant neoplasms in renal transplant patients: a 24-years experience. Transplant Proc 1992; 24: 1802–1803.
   PubMed Web of Science ®Google Scholar
• Brünisholz M, Hodel K, Brunner FP, Harder F, Torhorst J, Thiel G. Tumoren nach Nierentransplantation. Schweiz Med Wochenschr 1984; 114: 1915–1924.
   PubMedGoogle Scholar
• Brynger H, Ahlmen J, Bitter H, et al. Complications after renal transplantation. Scand J Urol Nephrol 1976; 38: 113–120.
   Google Scholar
• Cassidy MJD, Disler PB, Swanepol CR, Jacobson JE, Pontin AR. De novo malignant tumours in renal transplantation recipients. S Afr Med J 1992; 62: 58–60.
   Google Scholar
• Cockburn I. Assessment of the risks of malignancy and lymphomas developing in patients using sandimmune. Transplant Proc 1987; 19: 1804–1807.
   PubMed Web of Science ®Google Scholar
• Disler PB, MacPhail AP, Meyers AM, Myburgh JA. Neoplasia after successful renal transplantation. Nephron 1981; 29: 119–123.
   PubMed Web of Science ®Google Scholar
• Grundmann R. Malignominzidenz und Sterblichkeitsrisiko nach Nierentransplantation. Versicherungsmedizin 1988; 5: 119–124.
   Google Scholar
• Hartevelt MM, Bouwes Bavinck JN, Koote AMM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506–509.
   PubMed Web of Science ®Google Scholar
• Hoppe-Seyler F, Kräusslich HG, Schlehofer JR. Symposium on human tumour viruses. J Cancer Res Clin Oncol 1993; 119: 243–247.
   PubMed Web of Science ®Google Scholar
• Kirchner S. Malignome nach Nierentransplantation (Dissertation). Berlin: Humboldt-Universität, 1995.
   Google Scholar
• Kirste G. Langzeit-Komplikationen bei transplantierten Patienten. TW Urol Nephrol 1994; 6: 169–171.
   Google Scholar
• Lenard V, Opelz G. Bluttransfusion und Organtransplantation. In: Müller-Eckhardt C. Transfusionsmedizin: Grundlagen, Therapie, Methodik. Berlin: Springer-Verlag, 1988.
   Google Scholar
• Lucius K, Oesterwitz H, Müller P, Blank W, May G. Transplantation der Nieren von Spendern mit Karzinomeigene Erfahrungen und Literaturübersicht. Z Urol Nephrol 1990; 83: 77–81.
   PubMedGoogle Scholar
• Mankin J, Hudson S, Barber WH, Deierhoi MH, Diethelm AG. A parametric analysis of the hazard of cancer after transplantation. Transplant Proc 1989; 21: 3201–3204.
   PubMed Web of Science ®Google Scholar
• Pecqueux JC, Schwarz A, Dieckmann KP, Offermann G. Cancer incidence in patients on chronic dialysis and in renal transplant recipients. Urol Int 1990; 45: 290–292.
   PubMed Web of Science ®Google Scholar
• Penn I. Cancer related to organ transplantation:summary and conclusions. In: Schmähl D, Penn I, eds. Cancer in organ transplantation recipients. Berlin: Springer-Verlag, 1991.
   Google Scholar
• Penn I. Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 1978; 83: 492–502.
   PubMed Web of Science ®Google Scholar
• Penn I, Brunson ME. Cancers after cyclosporine therapy. Transplant Proc 1988; 20 (Suppl 3): 885–892.
   PubMed Web of Science ®Google Scholar
• Raska K, Morrison AB, Raskova J. Humoral inhibitors on the immune response in uremia. III. The Immunosuppressive factor of uremic rat serum is a very low density lipoprotein. Lab Invest 1980; 42: 636–640.
   PubMed Web of Science ®Google Scholar
• Roeger LS, Sheil AGR, Disney APS, Mathew TH, Amiss N. Risk factors associated with the development of squamous in immunsuppressed renal transplant patients. Clin Transplant 1992; 6: 202–211.
   Web of Science ®Google Scholar
• Sheil AGR. Cancer after transplantation. World J Surg 1986; 10: 389–396.
   PubMed Web of Science ®Google Scholar
• Sheil AGR, Disney APS, Mathew TG, Amiss N, Excell L. Malignancy following renal transplantation. Transplant Proc 1991; 24: 1946–1947.
   Web of Science ®Google Scholar
• Sheil AGR, Flavel S, Disney APS, Mathew TH. Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc 1985; 17: 1685–1688.
   PubMed Web of Science ®Google Scholar
• Sheil AGR, Mahony JF, Horvath JS, et al. Cancer and survival after cadaveric donor renal transplantation. Transplant Proc 1979; 11: 1052–1054.
   PubMed Web of Science ®Google Scholar
• Sloan GM, Cole P, Wilson RE. Risk indicators of de novo malignancy in renal transplant recipients. Transplant Proc 1977; 9: 1129–1132.
   PubMed Web of Science ®Google Scholar
• Sodomann CP. Über Malignomgefahr durch Immunsuppression nach Nierentransplantation. In: Albert FW, Seybold-Epting W, Kreiter H, eds. Praxis der Nierentransplantation (II) Stuttgart: Schattauer-Verlag, 1984.
   Google Scholar
• Starzl TE, Porter KA, Iwatsuki S, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid-therapy. Lancet 1984; 1: 583–587.
   PubMed Web of Science ®Google Scholar
• Sterioff S, Rios CN, Zachary JB, Williams GM. Neoplasia in kidney transplant recipients. Am J Surg 1975; 130: 622–626.
   PubMed Web of Science ®Google Scholar
• Tokoro J, Asano T, Nakagouri T, et al. A statistical study of cancer incidence in renal transplant patients. Transplant Proc 1992; 24: 1588–1590.
   PubMed Web of Science ®Google Scholar
• Vilardell J, Oppenheimer F, Castelao AM, et al. Cancer after transplantation in Catalonia. Transplant Proc 1992; 24: 124.
   PubMed Web of Science ®Google Scholar
• Vogt P, Frei U, Repp H, Bunzendahl H, Oldhafer K, Pichlmayr R. Malignant tumours in renal transplant recipients receiving cyclosporin: survey of 598 first-kidney transplantations. Nephrol Dial Transpl 1990; 5: 282–288.
   PubMed Web of Science ®Google Scholar
• Vollenweider A, Largaider F, Uhlschmid G, Binswanger U, Briner J. Maligne Tumoren bei Nierentransplanta-tempfngern unter immunsuppressiver Therapie. Schweiz Med Wochenschr 1982; 11: 102–111.
   Google Scholar
• Walz MK, Albrecht KH, Niebel W, Eigler FW. De-novo Malignome unter medikament—ser Immunsuppression. Dtsch Med Wochenschr 1992; 117: 927–934.
   PubMedGoogle Scholar